List of Tables
Table 1. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Chemical Drug Research And Development
Table 3. Key Players of Biological Drug Research And Development
Table 4. Key Players of Traditional Chinese Medicine Research And Development
Table 5. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million), 2021–2026
Table 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2021–2026)
Table 9. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2027–2032)
Table 11. Pharmaceutical R&D Outsourcing Services (CRO) Market Trends
Table 12. Pharmaceutical R&D Outsourcing Services (CRO) Market Drivers
Table 13. Pharmaceutical R&D Outsourcing Services (CRO) Market Challenges
Table 14. Pharmaceutical R&D Outsourcing Services (CRO) Market Restraints
Table 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue by Players (US$ Million), 2021–2026
Table 16. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Players (2021–2026)
Table 17. Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmaceutical R&D Outsourcing Services (CRO) Revenue, 2025
Table 18. Ranking of Global Top Pharmaceutical R&D Outsourcing Services (CRO) Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Pharmaceutical R&D Outsourcing Services (CRO) Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Headquarters and Area Served
Table 21. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Products and Applications
Table 22. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (US$ Million), 2021–2026
Table 25. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Type (2021–2026)
Table 26. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Type (2027–2032)
Table 28. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (US$ Million), 2021–2026
Table 29. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Application (2021–2026)
Table 30. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Application (2027–2032)
Table 32. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2021–2026
Table 34. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (US$ Million), 2027–2032
Table 47. IQVIA HOLDINGS Company Details
Table 48. IQVIA HOLDINGS Business Overview
Table 49. IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 50. IQVIA HOLDINGS Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 51. IQVIA HOLDINGS Recent Development
Table 52. ICON (incl. PRA Health) Company Details
Table 53. ICON (incl. PRA Health) Business Overview
Table 54. ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 55. ICON (incl. PRA Health) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 56. ICON (incl. PRA Health) Recent Development
Table 57. PPD(Pharmaceutical Product Development) Company Details
Table 58. PPD(Pharmaceutical Product Development) Business Overview
Table 59. PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 60. PPD(Pharmaceutical Product Development) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 61. PPD(Pharmaceutical Product Development) Recent Development
Table 62. Laboratory Corporation Company Details
Table 63. Laboratory Corporation Business Overview
Table 64. Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 65. Laboratory Corporation Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 66. Laboratory Corporation Recent Development
Table 67. Syneos Health Company Details
Table 68. Syneos Health Business Overview
Table 69. Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 70. Syneos Health Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 71. Syneos Health Recent Development
Table 72. Parexel Company Details
Table 73. Parexel Business Overview
Table 74. Parexel Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 75. Parexel Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 76. Parexel Recent Development
Table 77. Covance Company Details
Table 78. Covance Business Overview
Table 79. Covance Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 80. Covance Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 81. Covance Recent Development
Table 82. Charles River Laboratories Company Details
Table 83. Charles River Laboratories Business Overview
Table 84. Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 85. Charles River Laboratories Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 86. Charles River Laboratories Recent Development
Table 87. Wuxi AppTec Company Details
Table 88. Wuxi AppTec Business Overview
Table 89. Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 90. Wuxi AppTec Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 91. Wuxi AppTec Recent Development
Table 92. Pharmaron Inc. Company Details
Table 93. Pharmaron Inc. Business Overview
Table 94. Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 95. Pharmaron Inc. Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 96. Pharmaron Inc. Recent Development
Table 97. Hangzhou Tigermed Consulting Company Details
Table 98. Hangzhou Tigermed Consulting Business Overview
Table 99. Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 100. Hangzhou Tigermed Consulting Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 101. Hangzhou Tigermed Consulting Recent Development
Table 102. IQVIA Company Details
Table 103. IQVIA Business Overview
Table 104. IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 105. IQVIA Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 106. IQVIA Recent Development
Table 107. Joinn Laboratories (China) Company Details
Table 108. Joinn Laboratories (China) Business Overview
Table 109. Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 110. Joinn Laboratories (China) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (US$ Million), 2021–2026
Table 111. Joinn Laboratories (China) Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Pharmaceutical R&D Outsourcing Services (CRO) Picture
Figure 2. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Type: 2025 vs 2032
Figure 4. Chemical Drug Research And Development Features
Figure 5. Biological Drug Research And Development Features
Figure 6. Traditional Chinese Medicine Research And Development Features
Figure 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Application: 2025 vs 2032
Figure 9. Drug Discovery And Early Research Case Studies
Figure 10. Preclinical Research Case Studies
Figure 11. Clinical Trials Case Studies
Figure 12. Post-Marketing Follow-Up Case Studies
Figure 13. Other Case Studies
Figure 14. Pharmaceutical R&D Outsourcing Services (CRO) Report Years Considered
Figure 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region: 2025 vs 2032
Figure 18. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Players in 2025
Figure 19. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Pharmaceutical R&D Outsourcing Services (CRO) Revenue in 2025
Figure 21. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2021–2032)
Figure 23. United States Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2021–2032)
Figure 27. Germany Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2021–2032)
Figure 35. China Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2021–2032)
Figure 43. Mexico Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2021–2032)
Figure 47. Israel Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. IQVIA HOLDINGS Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 51. ICON (incl. PRA Health) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 52. PPD(Pharmaceutical Product Development) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 53. Laboratory Corporation Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 54. Syneos Health Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 55. Parexel Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 56. Covance Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 57. Charles River Laboratories Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 58. Wuxi AppTec Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 59. Pharmaron Inc. Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 60. Hangzhou Tigermed Consulting Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 61. IQVIA Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 62. Joinn Laboratories (China) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed